EPI Update, March 20, 2009 by unknown
EPI Update for Friday, March 20, 2009 
Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
  
  
Items for this week’s EPI Update include: 
• Neisseria meningitidis risk for laboratory workers 
• All children should receive primary series of Hib vaccine 
• Public health in action 
• Iowa Disease Surveillance System update 
• Infection control practitioner or infection preventionist? 
• Meeting announcements and training opportunities 
 
Neisseria meningitidis risk for laboratory workers 
Neisseria meningitidis has caused deaths in exposed laboratorians; the risk of 
exposure is from aerosols, splashes, splatters or sprays. A MMWR article in 
2002, reported exposure of laboratorians doing open bench work with N. 
meningitidis  (preparing a suspension or performing a catalase test); 11 of the 13 
infections were fatal.   
  
All laboratory work with cultures of known or suspect N. menigitidis must be 
performed inside a biological safety cabinet. If a laboratory worker has been 
exposed via manipulating a known N. menigitidis culture outside of a biological 
safety cabinet, immediate prophylactic antibiotic treatment is recommended to 
reduce the risk of infection and colonization.   
  
The Centers for Disease Control and Prevention (CDC) also recommends that 
microbiologists who may work with Neisseria meningitidis be vaccinated. To view 
the MMWR article visit, www.cdc.gov/mmwr/preview/mmwrhtml/mm5107a1.htm. 
  
All children should receive primary series of Hib vaccine 
  
All young children should be appropriately vaccinated with the 2- to 3-dose 
(depending on brand) primary series of Hib (Haemophilus influenzae type b) 
vaccine.  A nationwide shortage of Hib vaccine began in December 2007 and is 
ongoing. The cessation of production of Hib vaccines by Merck has left only one 
manufacturer of Hib vaccine in the United States (Sanofi Pasteur). The shortage 
resulted in a recommendation by CDC to defer the Hib booster (routinely 
recommended at 12 months through 15 months) for children who are NOT at 
high risk of Hib infection temporarily, until supplies are restored. This 
recommendation is still in effect so there is potential to see an increase in cases 
of Hib disease at the local level.  
  
All children should complete the primary series by 7 months of age; high risk 
children should continue to receive the full primary series and the booster dose. 
  
• Completion of the primary series with currently available vaccine 
products (manufactured by Sanofi Pasteur) requires a total of 3 doses 
of Hib-containing vaccine (2, 4, and 6 months). 
• Children who have received PedvaxHib (manufactured by Merck) 
require a total of 2 doses of vaccine (2, and 4 months) for a primary 
series. 
  
Although there is enough Hib-containing vaccine nationally to support these 
recommendations, there may be times when practitioners do not have an 
adequate supply of vaccine to meet local demand. If Hib vaccine is not available 
in the office at the time of a visit, these children should be tracked and receive 
their dose as soon as vaccine becomes available in the office. 
  
For more information about Hib disease and vaccination contact the Iowa 
Department of Public Health’s Immunization Program at 1-800-831-6293. 
  
Public health in action 
On March 3rd a hungry IDPH employee visited a local Des Moines deli for lunch, 
and ordered a sandwich that contained alfalfa sprouts. After being seated and 
served, but before he dug into the sandwich, the employee was approached by 
the deli manager.  The manager kindly told him that the sandwich contained 
sprouts that had just been recalled! The manager then offered a different 
sandwich, which the IDPH employee accepted; averting potential exposure to 
salmonella bacteria.     
  
This is an excellent example of public health at work (and KUDOS to the deli 
manager!).  The Salmonella Saintpaul outbreak investigation that lead to alfalfa 
sprouts being identified as the source resulted in the sprout producer removing 
this product from the market. The information then passed through the proper 
channels and made its way retail vendors. This likely prevented our employee 
and many more people from becoming ill.  Thanks to everyone who helped stop 
this outbreak.  
  
Iowa Disease Surveillance System update 
On October 27th, 2008, CADE began using an electronic system for reporting 
diseases called the Iowa Disease Surveillance System (IDSS), and since then 
IDSS has been released to all local public health agencies, and the enrolled 
hospitals and private laboratories located in all parts the state. While not all these 
facilities have yet installed IDSS, approximately 55 percent have installed and 
used the system. Today, 219 users have logged into the system, most (192) are 
local IDSS users, working at public health entities, hospitals or labs at 122 
facilities across Iowa.  
  
Since December 4th, 2008, when the first local user logged into IDSS, 757 new 
cases of reportable disease have been reported in the system. All these cases 
either have been or are being investigated by local or state public health staff and 
evaluated by an epidemiologist in CADE.  
While the system is still in a period of transition and is very early in its 
implementation, this new surveillance system has been well received. A second 
version of IDSS will be released very soon which includes four new types of 
reports that can be generated by users, and a number of other small useful 
enhancements. These upgrades will occur seamlessly and automatically; no 
action on the user’s part – other than logging in – is required to take advantage of 
these upgrades. 
  
Infection control practitioner or infection preventionist? 
Many of us have noticed a change lately in the title used for personnel 
performing infection prevention activities in hospitals. While the title most familiar 
to us is “infection control practitioner” (ICP); there is a growing movement to 
consider ICPs as “infection preventionists” (IP) since their efforts are more 
accurately described as preventing infections rather than just controlling them. 
The Association for Professionals in Infection Control and Epidemiology, (APIC) 
is the organization that ICPs/IPs work with and has regularly championed this 
prevention goal as the proper focus. So you may hear the term “infection 
preventionist” more often in the future.  We in public health applaud all their 
efforts no matter what title they use.  
  
Meeting announcements and training opportunities 
Immunize for a Better Life, the 2009 Iowa Immunization Conference 
will be held June 10-11 at the Hy-Vee Hall in Des Moines. See the brochure at: 
www.idph.state.ia.us/adper/common/pdf/immunization/conf_card.pdf.  
  
Have a healthy and happy week! Enjoy the great weather. 
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